Purchase Order N3239817P0222
Award Date 4/17/17
Potential Completion Date 4/16/18
Potential Value $89K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Illumina, Inc. is a purchase order (PO) for a MiSeq System, a genomic sequencing instrument, valued at $95,931.00. The award was made by the U.S. Navy Bureau of Medicine and Surgery (BUMED) and is not associated with a set-aside program. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing these products and related services to various federal agencies, including the National Institutes of Health (NIH),...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for $97,678.20. The award provides Illumina's RNA sequencing products and reagents to support the Naval Health Research Center's (NHRC) laboratory work characterizing biological threats. The contract has a period of performance through December 1, 2021. This award is not associated with a set-aside program. Illumina has previously...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- This is a delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $67,493.84 fixed-price contract is for the provision of medical laboratory supplies, specifically reagents and controls for Illumina's MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms. These instruments are used by the Naval Medical Research Center's Biological Defense Research Directorate to characterize...
- This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $249,894.20 contract is for the delivery of an Illumina MiSeq sequencing system, to be used at the agency's location in Rockville, Maryland. Illumina has provided similar sequencing systems and related supplies to support genomic research and diagnostics at various federal agencies, including...
- This federal contract award, valued at $161,610.94, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc. as the prime contractor. The award is for the delivery of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of Medicine and...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $15,807.96 award provides Illumina's proprietary sequencing systems, reagents, and services to support nucleic acid sequencing needs, with no set-aside designation. The order is part of a larger Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, valued up...
- The Bureau of Medicine and Surgery (BUMED) awarded a $12,990.38 firm fixed-price purchase order to Illumina, Inc. on November 11, 2025, for specialized molecular biology reagents and diagnostic kits with an ultimate completion date of February 6, 2026. The contract covers a MiSeq Reagent Nano Kit V2 (300-cycles) and an Illumina Respiratory Virus Enrichment Kit Set A, both critical components for next-generation sequencing applications. Performance will take place in San Diego, California,...